Pasithea Therapeutics Corp. Cash And Cash Equivalents At Carrying Value

Quick Answer

Pasithea Therapeutics Corp. reported Cash And Cash Equivalents At Carrying Value of $55.16 million for the year ending 2025.

  • Pasithea Therapeutics Corp. showed an increase of +696.8% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
  • This data is from Pasithea Therapeutics Corp.'s annual report (Form 10-K), filed with the SEC on March 30, 2026.
  • XBRL data for this metric is available from 2020 to 2025 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 6 years of available data (2020 to 2025), Pasithea Therapeutics Corp.'s Cash And Cash Equivalents At Carrying Value has grown by 22,538.6%.
  • Historical annual values: Fiscal year 2025: $55.16 million | Fiscal year 2024: $6.92 million | Fiscal year 2023: $16.33 million | Fiscal year 2022: $33.09 million | Fiscal year 2021: $52.97 million | Fiscal year 2020: $243.7 thousand.
  • Data sourced from SEC EDGAR public filings as of June 23, 2026.

Last verified: